0001209191-18-016827.txt : 20180305 0001209191-18-016827.hdr.sgml : 20180305 20180305181319 ACCESSION NUMBER: 0001209191-18-016827 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180302 FILED AS OF DATE: 20180305 DATE AS OF CHANGE: 20180305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCGLYNN MARGARET G CENTRAL INDEX KEY: 0001215126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 18667930 MAIL ADDRESS: STREET 1: C/O MERCK & CO INC STREET 2: ONE MERCK DRIVE PO BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-02 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001215126 MCGLYNN MARGARET G C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2018-03-02 4 M 0 10000 81.54 A 16312 D Common Stock 2018-03-02 4 S 0 10000 170.00 D 6312 D Stock Option (Right to Buy) 81.54 2018-03-02 4 M 0 10000 0.00 D 2023-05-31 Common Stock 10000 10000 D Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1. Fully vested. /s/ Omar White, Attorney-in-Fact 2018-03-05